U.S. probing two new blood clot cases after J&J's COVID-19 vaccine

1 minute read

Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic

Register now for FREE unlimited access to Reuters.com

April 27 (Reuters) - Two new cases of blood clots after administration of Johnson & Johnson's (JNJ.N) single-dose COVID-19 vaccine are being investigated by federal health officials, the U.S. Centers for Disease Control and Prevention said on Tuesday.

One case was in a male and the other was in a female, both of whom were below 60 years, according to the agency, taking the total number of confirmed such cases to 17 out of 8 million shots given.

The new cases come after U.S. health regulators on Friday recommended resumption of use of J&J's shot, ending a 10-day pause to investigate its link to extremely rare but potentially deadly blood clots. read more

The CDC and the Food and Drug Administration said on Friday the risks of experiencing the syndrome involving severe blood clots and low platelets as a result of the vaccine were very low.

Register now for FREE unlimited access to Reuters.com
Reporting by Ankur Banerjee and Manojna Maddipatla in Bengaluru; Editing by Shailesh Kuber

Our Standards: The Thomson Reuters Trust Principles.